BlackRock Amends Merck Stake: Passive Investment Continues

Ticker: MRK · Form: SC 13G/A · Filed: 2024-01-26T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, passive-investment, amendment, pharmaceuticals

Related Tickers: MRK

TL;DR

**BlackRock still owns Merck, signaling institutional confidence.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership of Merck & Co., Inc. common stock as of December 31, 2023. This filing, Amendment No. 14, indicates BlackRock's continued significant, but passive, investment in Merck. For investors, this means a major institutional holder maintains its position, signaling confidence in Merck's long-term prospects, which can be a positive indicator for the stock's stability.

Why It Matters

This filing confirms BlackRock, a major institutional investor, still holds a significant stake in Merck, which can reassure current and potential investors about the stock's stability and institutional backing.

Risk Assessment

Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate risks or significant changes in strategy.

Analyst Insight

Investors should view this as a routine update confirming continued institutional interest in Merck, rather than a signal for immediate action. It reinforces the stability of Merck's institutional ownership base.

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 14, as stated in the filing.

Who is the 'subject company' in this filing?

The subject company, whose securities are being reported, is Merck & Co., Inc., with CIK 0000310158, as identified in the 'SUBJECT COMPANY' section.

Who is the 'filing person' or 'reporting person' in this document?

The filing person, also known as the reporting person, is BlackRock Inc., with CIK 0001364742, as identified in the 'FILED BY' section.

What is the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023, as explicitly stated on the cover page of the Schedule 13G.

Under which rule is this Schedule 13G/A filed?

This Schedule 13G/A is filed under Rule 13d-1(b), indicated by the 'X' next to '[X] Rule 13d-1(b)' on the cover page.

From the Filing

0001086364-24-004323.txt : 20240126 0001086364-24-004323.hdr.sgml : 20240126 20240126114942 ACCESSION NUMBER: 0001086364-24-004323 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-33582 FILM NUMBER: 24565829 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us58933y1055_012624.txt us58933y1055_012624.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14) MERCK & CO INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 58933Y105 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 58933Y105 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 182531000 (6) Shared voting power 0 (7) Sole dispositive power 201836434 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 201836434 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 8.0% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- MERCK & CO INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 Item 2. 2(a) Name of person filing: ------

View on Read The Filing